HUE044211T2 - Staphylococcus aureus elleni immunizálásra szolgáló, stabilizált fehérjék - Google Patents

Staphylococcus aureus elleni immunizálásra szolgáló, stabilizált fehérjék

Info

Publication number
HUE044211T2
HUE044211T2 HUE13753327A HUE044211T2 HU E044211 T2 HUE044211 T2 HU E044211T2 HU E13753327 A HUE13753327 A HU E13753327A HU E044211 T2 HUE044211 T2 HU E044211T2
Authority
HU
Hungary
Prior art keywords
staphylococcus aureus
against staphylococcus
immunising against
stabilised
proteins
Prior art date
Application number
Other languages
English (en)
Inventor
Fabio Bagnoli
Fabiana Falugi
Guido Grandi
Massimo Mariani
Mikkel Nissum
Michele Pallaoro
Silvana Savino
Original Assignee
Glaxosmithkline Biologicals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biologicals Sa filed Critical Glaxosmithkline Biologicals Sa
Publication of HUE044211T2 publication Critical patent/HUE044211T2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
HUE13753327 2012-08-31 2013-08-29 Staphylococcus aureus elleni immunizálásra szolgáló, stabilizált fehérjék HUE044211T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261695723P 2012-08-31 2012-08-31

Publications (1)

Publication Number Publication Date
HUE044211T2 true HUE044211T2 (hu) 2019-10-28

Family

ID=49036594

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE13753327 HUE044211T2 (hu) 2012-08-31 2013-08-29 Staphylococcus aureus elleni immunizálásra szolgáló, stabilizált fehérjék

Country Status (15)

Country Link
US (1) US9926344B2 (hu)
EP (1) EP2890394B1 (hu)
JP (1) JP6435261B2 (hu)
CN (2) CN104619336A (hu)
CY (1) CY1121944T1 (hu)
DK (1) DK2890394T3 (hu)
ES (1) ES2737024T3 (hu)
HR (1) HRP20191166T1 (hu)
HU (1) HUE044211T2 (hu)
LT (1) LT2890394T (hu)
PL (1) PL2890394T3 (hu)
PT (1) PT2890394T (hu)
SI (1) SI2890394T1 (hu)
TR (1) TR201910573T4 (hu)
WO (1) WO2014033190A1 (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2014112343A (ru) * 2011-09-01 2015-10-10 Новартис Аг Оставы антигенов staphylococcus aureus, содержащие адъюванты
CN106103469B (zh) 2014-03-26 2020-11-27 葛兰素史密丝克莱恩生物有限公司 突变型葡萄球菌抗原
EP4438749A3 (en) 2016-11-14 2025-01-08 Lilac Solutions, Inc. Lithium extraction with coated ion exchange particles
JP6916042B2 (ja) * 2017-06-09 2021-08-11 株式会社明治 抗原特異的インターフェロンγ産生促進用組成物
US10439200B2 (en) 2017-08-02 2019-10-08 Lilac Solutions, Inc. Ion exchange system for lithium extraction
AR112663A1 (es) 2017-08-02 2019-11-27 Lilac Solutions Inc Extracción de litio con perlas porosas de intercambio iónico
KR20200116526A (ko) 2018-02-28 2020-10-12 리락 솔루션즈, 인크. 리튬 추출을 위한 입자 트랩을 가진 이온 교환 반응기
KR20220119166A (ko) 2020-01-09 2022-08-26 리락 솔루션즈, 인크. 바람직하지 않은 금속의 분리 방법
CN111595658B (zh) * 2020-06-06 2023-11-14 宾傲 一种提取细胞中蛋白的裂解液及其制备方法
CA3178825A1 (en) 2020-06-09 2021-12-16 David Henry SNYDACKER Lithium extraction in the presence of scalants
CA3199218A1 (en) 2020-11-20 2022-05-27 David Henry SNYDACKER Lithium production with volatile acid
KR20240014047A (ko) 2021-04-23 2024-01-31 리락 솔루션즈, 인크. 리튬 추출을 위한 이온 교환 장치
EP4499260A4 (en) 2022-03-28 2026-04-01 Lilac Solutions Inc DEVICES FOR THE EFFICIENT USE OF SORBANTS IN LITHIUM EXTRACTION
AR128953A1 (es) 2022-04-01 2024-06-26 Lilac Solutions Inc Extracción de litio con aditivos químicos

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS624300A (ja) 1985-06-28 1987-01-10 Dai Ichi Seiyaku Co Ltd 改良型ヒトガンマインタ−フエロンおよびその製造方法
EP0355460B1 (en) * 1988-08-24 2000-12-27 American Cyanamid Company Stabilization of somatotropins by modification of cysteine residues utilizing site directed mutagenesis or chemical derivatization
CA2017507C (en) 1989-05-25 1996-11-12 Gary Van Nest Adjuvant formulation comprising a submicron oil droplet emulsion
US5874238A (en) 1993-02-26 1999-02-23 Immtech International Inc. Mutant protein and methods and materials for making and using it
WO1995011700A1 (en) 1993-10-29 1995-05-04 Pharmos Corp. Submicron emulsions as vaccine adjuvants
US6080725A (en) 1997-05-20 2000-06-27 Galenica Pharmaceuticals, Inc. Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
NZ508013A (en) 1998-05-07 2003-08-29 Corixa Corp Adjuvant composition for use with an antigen in a vaccine composition
KR100629028B1 (ko) 1998-10-16 2006-09-26 글락소스미스클라인 바이오로지칼즈 에스.에이. 애쥬번트 시스템 및 백신
GB9825421D0 (en) * 1998-11-19 1999-01-13 Isis Innovation Process for oxidising terpenes
WO2000046147A2 (en) 1999-02-03 2000-08-10 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles and methods of manufacture and use
KR100382239B1 (ko) 2000-02-17 2003-04-26 주식회사 엘지생명과학 황색 포도상 구균의 변이 독소 에스이씨-에스이알, 그것의발현벡터 및 숙주세포, 그 생산방법 및 백신제조방법
IL152804A0 (en) * 2000-05-16 2003-06-24 Bolder Biotechnology Inc Methods for refolding proteins containing free cysteine residues
GB0107661D0 (en) * 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
KR20110132416A (ko) 2004-04-05 2011-12-07 화이자 프로덕츠 인코포레이티드 미세유체화된 수중유 유화액 및 백신 조성물
US20060228369A1 (en) 2005-04-11 2006-10-12 Program For Appropriate Technology In Health Stabilization and preservation of temperature-sensitive vaccines
US7691368B2 (en) 2005-04-15 2010-04-06 Merial Limited Vaccine formulations
US8703095B2 (en) 2005-07-07 2014-04-22 Sanofi Pasteur S.A. Immuno-adjuvant emulsion
EP1931379B1 (en) 2005-10-07 2013-05-29 Health Protection Agency Proteins with improved solubility and methods for producing and using same
FR2896162B1 (fr) 2006-01-13 2008-02-15 Sanofi Pasteur Sa Emulsion huile dans eau thermoreversible
AU2007281934B2 (en) 2006-01-18 2012-11-15 University Of Chicago Compositions and methods related to Staphylococcal bacterium proteins
EA015817B1 (ru) 2006-10-12 2011-12-30 Глаксосмитклайн Байолоджикалс С.А. Иммуногенная композиция, содержащая адъювант в виде эмульсии "масло в воде"
UY31930A (es) * 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
EP3263128A3 (en) 2009-04-14 2018-01-24 GlaxoSmithKline Biologicals S.A. Compositions for immunising against staphylococcus aureus
WO2011027222A2 (en) 2009-09-02 2011-03-10 Novartis Ag Immunogenic compositions including tlr activity modulators
BR112012009014B8 (pt) * 2009-09-30 2022-10-04 Novartis Ag Processo para preparar conjugado de polissacarídeo capsular de s. aureus tipo 5 ou tipo 8 e molécula de transporte crm197, conjugado e composição imunogênica
HUE034251T2 (hu) * 2009-10-30 2018-02-28 Glaxosmithkline Biologicals Sa Staphylococcus aureusból származó 5. típusú és 8. típusú kapszuláris szacharidok tisztítása
JP2011212008A (ja) * 2010-03-16 2011-10-27 Olympus Corp 蛍光タンパク質およびｐＨ測定方法
RU2014112343A (ru) * 2011-09-01 2015-10-10 Новартис Аг Оставы антигенов staphylococcus aureus, содержащие адъюванты
CN104023744A (zh) 2011-12-23 2014-09-03 诺华股份有限公司 用于针对金黄色葡萄球菌免疫的稳定组合物

Also Published As

Publication number Publication date
JP6435261B2 (ja) 2018-12-05
EP2890394B1 (en) 2019-05-01
EP2890394A1 (en) 2015-07-08
HRP20191166T1 (hr) 2019-10-04
PT2890394T (pt) 2019-07-15
TR201910573T4 (tr) 2019-08-21
LT2890394T (lt) 2019-07-25
DK2890394T3 (da) 2019-07-15
CN104619336A (zh) 2015-05-13
ES2737024T3 (es) 2020-01-09
SI2890394T1 (sl) 2019-06-28
JP2015528455A (ja) 2015-09-28
US20150203542A1 (en) 2015-07-23
CY1121944T1 (el) 2020-10-14
US9926344B2 (en) 2018-03-27
CN110563818A (zh) 2019-12-13
WO2014033190A1 (en) 2014-03-06
PL2890394T3 (pl) 2019-12-31

Similar Documents

Publication Publication Date Title
LT2890394T (lt) Stabilizuoti baltymai skirti imunizavimui nuo staphylococcus aureus
PL3295781T3 (pl) Kosiarka robotyczna
PL2912020T3 (pl) Fungicydy podstawione tolilem
GB201206598D0 (en) Herbicidal compounds
GB201205657D0 (en) Herbicidal compounds
EP2828257A4 (en) ANTIBACTERIAL COMPOUNDS
GB201218813D0 (en) Antimicrobial peptides
ZA201405950B (en) Short antimicrobial lipopeptides
GB201205654D0 (en) Herbicidal compounds
ZA201503372B (en) Antimicrobial agents
PT2833929T (pt) Penso antimicrobiano
AP2015008503A0 (en) Antibacterial compounds
ZA201504362B (en) Pest control agent
GB201211202D0 (en) Antimicrobial compounds
GB201217868D0 (en) Staphyolococcus aureus antigens
GB201211203D0 (en) Antimicrobial compounds
IL239207A0 (en) Antibacterial compounds
GB201219148D0 (en) Herbicidal compounds
GB201205662D0 (en) Herbicidal compounds
GB201205656D0 (en) Herbicidal compounds
GB201205658D0 (en) Herbicidal compounds
GB201205660D0 (en) Herbicidal compounds
GB201204894D0 (en) Herbicidal compounds
GB201204893D0 (en) Herbicidal compounds
GB201204724D0 (en) Herbicidal compounds